A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Exclusion Criteria

• •Women of childbearing potential are excluded from the study.
• •Have known allergies to imlunestrant or related compounds
• •Have a history of alcoholism or drug/chemical abuse within 2 years prior to check-in
• •Have received blood products within 2 months prior to check-in
• •Have evidence of HIV infection and/or positive human HIV antibodies
• •Have used or intend to use medications that are strong inhibiters or inducers of cytochrome P450 (CYP)3A4
• •Who smoke more than 10 cigarettes or use the equivalent tobacco, smoking-cessation products, nicotine-containing products, or e-cigarettes (nicotine and non-nicotine) per day.
• •Have a history or presence of cardiovascular (eg, symptomatic bradycardia with resting heart rate of \<60 beats per minute), respiratory, renal, gastrointestinal, endocrine, hematological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs